BioMed Research International / 2016 / Article / Tab 3

Research Article

Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension

Table 3

Echocardiographic and hemodynamic data.

All patients
Patients
without
nsVT
Patients
with
nsVT
p value

Echocardiography
 RA diameter (mm)41.741.244.60.247
 RV diameter (mm)38.938.441.80.197
 sPAP (mmHg)63.361.672.70.163
 TAPSE (mm)20.120.915.70.001
Right heart catheterization
 mPAP (mmHg)40.840.247.70.865
 RAP (mmHg)4.74.44.30.310
 PCWP (mmHg)7.97.87.20.688
 PVR (dyn⋅s⋅cm−5)5635328350.353
 CI (l/min/m2)2.732.812.420.390
 ven sO2 (%)6768640.700

CI: cardiac index; cm: centimeter; dyn: Dyne; Hg: mercury; l: liter; m: meter; mm: millimeter; mPAP: mean pulmonary arterial pressure; n: number; nsVT: nonsustained ventricular tachycardia; PCWP: pulmonary capillary wedge pressure; mPAP: mean pulmonary arterial pressure; PVR: pulmonary vascular resistance; RA: right atrium; RAP: right atrial pressure; RV: right ventricle; s: second; sPAP: systolic pulmonary arterial pressure; TAPSE: tricuspid annular plane systolic excursion; ven sO2: venous oxygen saturation.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.